ERBB2 and neoplasm: This usually consists of a local (surgical tumor resection) and a systemic therapy according to the molecular subtype, including endocrine treatment, antibodies against HER2, and chemotherapy, with a trend towards neoadjuvant systemic treatment in recent years.